Investigators evaluated whether the addition of carboplatin to neoadjuvant chemotherapy improved efficacy outcomes in patients with early-stage TNBC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback